• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

What's It Like to Be Bought?

Article

Pharmaceutical Executive

Pharmaceutical ExecutivePharmaceutical Executive-06-18-2007
Volume 0
Issue 0

It's easy to imagine a collective gasp from independent healthcare agencies everywhere last March on hearing the that news Dorland Global was bought by London-based Huntsworth. Dorland was one of the oldest independent healthcare agencies in the world. Is it right, then, to view the acquisition as significant, a sign perhaps of things to come? And what was it like for the Sweeneys to let go of their baby after all these years?

DIRECTIVE:

It's easy to imagine a collective gasp from independent healthcare agencies everywhere last March on hearing the that news Dorland Global was bought by London-based Huntsworth. Dorland was one of the oldest independent healthcare agencies in the world. Is it right, then, to view the acquisition as significant, a sign perhaps of things to come? And what was it like for the Sweeneys to let go of their baby after all these years?

FINDINGS

Owned (along with eight other shareholders) by agency legends Rita and Harry Sweeney (pictured here), Dorland was sold to the British firm Huntsworth for a total of $20.7 million upfront (though the total amount paid through 2010 could be $50 million based on Dorland's profitability over the next three years). In May, Dorland was ranked as the third-most-profitable healthcare agency by Advertising Age, with revenue for 2006 listed at $33.1 million, a 32 percent change from 2005.

Huntsworth has 60 offices and 1,650 employees worldwide. Dorland will be part of its Huntsworth Health Division, which offers marketing, Internet service, and public and professional relations, as well as branding and a variety of marketing communications.

Rita Sweeney and Dorland, in a sense, grew up together. After graduating from the University of Pennsylvania's Wharton School, Rita began a career in public relations. She shifted from public relations to advertising account management after purchasing Dorland with her husband, Harry, in 1975. Rita's love of PR led her to pioneer its integration with traditional advertising campaigns, as well as with carefully planned issues-and crisis-management programs and product launches.

As Dorland grew, so did Rita, acquiring new skills in general agency management while filling the role of executive vice president. Rita became president and COO of Dorland Global in 1998.

Much admired in the field, Rita has garnered numerous awards, including being named one of the Top 50 Business Women in Pennsylvania.

UNDERCOVER: RITA SWEENEY

AGENCY CONFIDENTIAL: So, why did you do it? Why, as the oldest independent agency and one of the most successful, go the acquisition route now?

Rita: Independence was important, and for a long time it was a competitive advantage for us. It gave us a unique selling position. As an independent, we believed we were able to accomplish everything that a publicly held agency could. We had the top-tier talent; we had the global accounts; we had the award winning creative.... But, our focus was on business practicalities in a rapidly changing environment. The fact of the matter is that the evolving healthcare-marketing landscape is heading in a new direction. The competitive advantage we enjoyed as an independent for decades just wasn't going to be on par with the needs of the marketplace within a few short years.

AC: How do you see those needs?

Rita: In today's environment, clients want an agency with a true footprint in markets around the globe. It's not good enough anymore to just have a loose agreement with a partner agency that allows you to put a dot on a map during a pitch and say you're global. The marketing and communications teams at healthcare companies today are dealing with increasingly complex situations, and juggling multiple agencies in multiple markets adds work for them and is almost guaranteed to create a lack of alignment somewhere along the way. Clients want to know that if they need a program in Beijing or Berlin they can pick up the phone to talk to their agency in Philadelphia and coordinate everything from a central location.

AC: What was it like in the room when you were deciding that the Huntsworth deal was the right one for Dorland?

Rita: It was actually a rather exciting moment. We had many suitors for many years, but we were steadfast that we would only do a deal with the right partner—someone who understood our culture and who would preserve what we had all built. After years of looking at deals that didn't make sense for one reason or another, when the moment finally came, we looked around the table and said, "This is the one," it was really exhilarating.

AC: What will the new agency look like?

Rita: Dorland is now the U.S. footprint for Huntsworth Health, so while we may have relinquished our independent status, we are able to maintain the independent spirit that has defined us for decades. We are now working with David Rowley as CEO of Huntsworth Health, who built the largest integrated healthcare agency in the United Kingdom with similar entrepreneurial values. Our ownership has changed hands, but our culture and vision has not.

AC: Do you think it will be hard for you and your employees to change?

Rita: Not at all. We're no stranger to change. As a Philadelphia-based agency, we connected with the famous Benjamin Franklin quote: "When you're finished changing, you're finished." Perpetual change started for us back in 1975 when we purchased Dorland, the second-oldest general ad agency in the world, and changed it to a specialty healthcare-marketing agency (our personal expertise). Then we were one of the first to offer integrated program solutions when we added public relations to our core mix more than 20 years ago. We were among the first to understand how to harness the power of the consumer to create an entire category—not just drive a brand. We were the first to launch a blockbuster drug internationally (Tagamet). So, it's logical that we would return to our roots with a true global presence.

Related Videos